Friday, February 06, 2026

Lack of information hinders regulation of ‘green’ nanopesticides




Scientists warn that terms such as “sustainable” must be used correctly and that the natural components of these products do not eliminate environmental concerns.




Fundação de Amparo à Pesquisa do Estado de São Paulo

Lack of information hinders regulation of ‘green’ nanopesticides 

image: 

Evolution of weed control 7 days after application of green nanoherbicide, compared to control without application

view more 

Credit: Vanessa Takeshita





New formulations of nanopesticides with natural ingredients have appeared in specialized literature using terms such as “green pesticide,” “ecological,” “based on natural elements,” and “with natural nanoparticles,” among others. However, there is no consensus on what truly constitutes a green pesticide, and these terms are used even when the active ingredients are synthetic or conventional and only encapsulated in formulations based on natural polymers.

“Commercial formulations of pesticides used in the field consist of active ingredients and so-called co-formulants, such as surfactants, dispersing agents, and emulsifiers. They represent between 50% and 90% of the total composition of commercial products, but are often vaguely labeled as ‘inert compounds’ and poorly documented, although they can sometimes be more toxic to the environment than the active ingredient itself,” warns Vanessa Takeshita, lead author of a review on the subject published in Sustainable Materials and Technologies by the Environmental Nanotechnology Group at the Institute of Science and Technology of São Paulo State University (ICT-UNESP), Sorocaba campus, Brazil.

According to her, over the last 20 years of developing nanoformulations for agriculture, the academic community has changed its strategy and approach. Initially, the focus was on reducing the amount of the formulation deposited in the environment. “The focus was on gaining efficiency for dose reduction,” she recalls, emphasizing that nanotechnology was a fundamental tool for that purpose. She adds that the products of this first generation of nanoformulations are already better for the environment than the traditional formulations used in agriculture for decades, but they still need to reach the market. 

As the work progressed, however, the team led by Leonardo Fernandes Fraceto, currently innovation coordinator at the Center for Research on Biodiversity Dynamics and Climate Change (CBioClima), a FAPESP Research, Innovation, and Dissemination Center (RIDC), and coordinator of INCT NanoAgro, found that formulations with natural characteristics capable of promoting biorecognition by the plant tended to be more efficient. “When natural molecules or natural compounds are used, the plant identifies them as known compounds. We realized that it was easier and less environmentally hazardous to be efficient using non-synthetic ingredients. So, we moved forward in developing increasingly sustainable formulations.”

According to Takeshita, this “green shift” has been an international trend in research on the subject. However, she says the search for green nanoformulations has become a means of achieving publication and scientific dissemination. “If it has ‘green’ in the name, it gets media coverage, is published, and is successful. But is it really green? To answer this question, we began scrutinizing the published work. Sometimes the polymers and active ingredients are natural, but synthetic surfactants are used in the composition for stability, or only the polymer is natural. Therefore, these terms should be used sparingly to define this new generation of pesticides.”

According to her, a product must have an active ingredient and polymer of natural origin, as well as a clean production chain, to be considered “green.” Additionally, even if a product is classified as environmentally friendly, it is essential to assess its toxicity, as biodegradability does not exempt products from associated environmental impacts.

The article traces the history of green nanopesticide research and suggests a flowchart to help decision-makers classify formulations. Based on this information, they can then move forward with registering these new, efficient, environmentally safe molecules.  

“We believe that the registration process for proven green molecules should be facilitated. As long as it can be shown, throughout the various stages, that the product is more efficient, has low or no toxicity, that the formulation without the active ingredient is also non-toxic, and that the result is as good as that of a conventional formulation, or one that isn’t entirely green, the registration process could be accelerated. That’s what we’re proposing at the end of the study. We want green molecules to reach the market and producers more quickly,” the researcher argues.

Tracking and registration

Brazil still lacks specific standards for regulating nanoformulations. Everything is analyzed and reviewed on a case-by-case basis. Three institutions are involved in registering these new and conventional formulations: the Ministry of Agriculture and Livestock (MAPA), the Brazilian Health Regulatory Agency (ANVISA), and the Brazilian Institute of the Environment and Renewable Natural Resources (IBAMA). Europe is slightly ahead; the Organization for Economic Cooperation and Development (OECD) is developing guidelines to help regulate these products. Brazilian institutions require these guidelines for registering similar products, including tests of molecule mobility in the environment and toxicity levels. 

“We need to show MAPA that the formulation works at least as well as those already on the market; prove to ANVISA that the molecule has low toxicity, through a series of studies; and IBAMA will also request information on toxicity to non-target organisms, whether the molecule has the potential to reach groundwater, whether it’s mobile in the soil, whether it’s degradable in the environment, among other questions,” Takeshita explains. According to her, the process is usually lengthy, and even a conventional molecule can take more than ten years to be approved. 

The ideal regulatory mechanism for the agronomist would be a kind of bonus system: the greener the molecule, the faster the registration process. “But that doesn’t exempt companies from submitting all the necessary dossiers. Most likely, for nanoformulations, it’ll be necessary to submit all the studies that are already submitted for conventional pesticides, plus some additional information. The detailed characterization of this nanoparticle, for example, according to established and recognized criteria, will likely be an important step, since, as mentioned, it interacts differently with the environment.”

Nano vs. conventional

Vanessa Takeshita explains that conventional formulations are mixtures of ingredients, such as the surfactant, active ingredient, and emulsifier, that are blended together. “The molecules are loose in a mixture. This helps the active ingredient reach the plant, adhere to the surface, and remain present in the plant’s environment. A nanoformulation, on the other hand, is a structure that can be assembled in various formats, such as small squares made of layers of clay, capsules, or hydrogels. For pesticides, the capsule format [<1000 nm] is most interesting. In this case, the active ingredient is inside the capsule, which protects and carries it into the plant.”

There are many advantages. For example, the plant can be “tricked” by the capsule. The scientists call this mechanism a Trojan horse. “The plant recognizes the capsule as a compound that’s good for it, but it’s inside that the active ingredient is found. In the case of herbicides, which we need to apply to weeds in large quantities, we can apply a smaller dose because it’s possible to deliver more product directly into the plant, which is more efficient.” 

The researcher reiterates that progress has been made and that it is possible to have sustainable products that benefit agriculture. However, she acknowledges that there are bottlenecks. “It’s possible to have truly green formulations that can reach national and international markets and be used on a large scale, even for first-generation nanopesticides, i.e., those that combine synthetic or synthetic and natural compounds. The active ingredients can come from plants, microorganisms, or the substances they produce, but we know that there’s still a large gap in identifying these molecules, determining which compounds work, and extracting the active ingredients.”

Nanostructures, on the other hand, can be made with bioproducts such as zein, a protein extracted from corn; lignin, a biopolymer that supports plants; and cellulose, among others. “However, in addition to all the regulatory issues, the industry must be willing to adapt its industrial plants or develop these greener molecules for the market. A study has shown that producers are willing to pay 22% to 40% more for nanoformulations that are more efficient and less dangerous than conventional products. In other words, producers are willing to accept technology that helps them,” Takeshita summarizes.  

FAPESP also supported the work through a Regular Research Grant; four postdoctoral fellowships (24/07260-223/16519-723/00335-4, and 23/07905-0); a research internship abroad; a doctoral scholarship; and a scholarship for Retention of Young Doctors in Brazil

About São Paulo Research Foundation (FAPESP)
The São Paulo Research Foundation (FAPESP) is a public institution with the mission of supporting scientific research in all fields of knowledge by awarding scholarships, fellowships and grants to investigators linked with higher education and research institutions in the State of São Paulo, Brazil. FAPESP is aware that the very best research can only be done by working with the best researchers internationally. Therefore, it has established partnerships with funding agencies, higher education, private companies, and research organizations in other countries known for the quality of their research and has been encouraging scientists funded by its grants to further develop their international collaboration. You can learn more about FAPESP at www.fapesp.br/en and visit FAPESP news agency at www.agencia.fapesp.br/en to keep updated with the latest scientific breakthroughs FAPESP helps achieve through its many programs, awards and research centers. You may also subscribe to FAPESP news agency at http://agencia.fapesp.br/subscribe.

Bai lab secures two patents with EV industry partners



Making EVs even ‘cooler’



University of Tennessee at Knoxville

Bai Lab Secures Two Patents with EV Industry Partners 

image: 

University of Tennessee, Knoxville, Min H. Kao Department of Electrical Engineering and Computer Science Professor Hua “Kevin” Bai.

view more 

Credit: University of Tennessee





Last year, University of Tennessee, Knoxville Min H. Kao Department of Electrical Engineering and Computer Science Professor Hua “Kevin” Bai’s laboratory patented two technologies that will improve electric vehicle (EV) charging and power conversion.

Bai and his lab members have been actively applying and licensing the patents with their automotive industry collaborators, FORVIA HELLA and Volkswagen Group of America, to accelerate the impacts of the new technology.

“Industry researchers have a good sense of end users’ needs,” Bai said. “During collaborations, our industrial partners can guide us toward technology with real applications, which expedites the development of products once we arrive at the final design.”

Thanks to these patents and his previous innovations, Bai was also inducted as a fellow of the National Academy of Inventors last year.

“This is the highest honor of my academic career so far,” said Bai. “More importantly, it is the result of many patents generated through industry collaborations and then licensed back to the companies. Therefore, this title is also an acknowledgement of our close and effective collaborations with the automotive industry, and our broader contributions to society and the economy.”

Free Electric Flow in EVs

EV chargers convert the AC electricity coming from the power grid into high-voltage DC power, allowing it to be stored in the car’s main battery. A DC-DC converter inside the car splits some of the stored power off to a smaller, low-voltage battery that supplies energy to power steering, GPS, and other small electronic systems.

One of Bai’s new patents uses a coupled transformer to integrate the AC-DC and DC-DC converter units, reducing the cost and size of the car’s electrical components. The new technology was developed in collaboration with FORVIA HELLA, a European automotive component supplier that jointly holds the patent with Bai’s lab.

“This construction also allows power to flow freely between the AC grid, high-voltage car battery, and low-voltage car battery,” Bai explained. “That can be extremely useful if the propulsion battery is low; the low-voltage battery can kick in to provide extra power to get the vehicle the last few miles to a charging station.”

Cooler Semiconductors

EV chargers and internal DC-DC converters are able to convert power types and voltages thanks to semiconductor devices. As with any electronic device, these create heat during operation but cannot operate reliably if they get too hot.

Conventional off-the-shelf devices usually have bare dies (blocks of semiconductor material with integrated circuits) packaged within a thermal substrate; this package is mounted on a thermal interface material, then coupled to a heatsink. As the semiconductor operates, excess heat transfers to the heatsink.

Unfortunately, the extra layers of material slow heat transfer away from the die, which can actually contribute to overheating and shorten the die’s lifespan.

In collaboration with Volkswagen Group of America, which jointly holds this patent, Bai’s group removed several layers from this assembly.

“Our patented method directly solders the die to a specialized ceramic material with microchannels that coolant liquid can flow through, removing heat more effectively,” said Bai.

 

More isn’t always better: Texas A&M research links high-dose antioxidants to offspring birth defects



Findings suggest men planning to conceive should use caution with antioxidant supplements, as excess intake can influence sperm and early offspring craniofacial development.



Texas A&M University





Antioxidants have been marketed as miracle supplements, touted for preventing chronic diseases and cancers; treating COPD and dementia; and slowing aging.

While antioxidant therapies are widely used to treat male infertility, a new study from the Texas A&M College of Veterinary Medicine and Biomedical Sciences (VMBS) found that regularly consuming high doses of antioxidants negatively influences sperm DNA and may lead to offspring born with differences in craniofacial development.

In a study, published in the journal Frontiers in Cell and Developmental Biology, a team of researchers led by Dr. Michael Golding examined the effects of N-acetyl-L-cysteine (NAC) and selenium (Se) — two widely used antioxidants — in mouse models.

They found that offspring of male mice exposed to antioxidants for six weeks exhibited skull and facial shape differences, even while the father’s health didn’t change.

These findings suggest that men should exercise caution when consuming high doses of antioxidants, especially if they’re planning to have children in the near future.   

When good goes too far

Antioxidants like NAC — which is a key ingredient in many nutritional supplements, including multivitamins — are often used to treat oxidative stress, which can be caused by excessive alcohol consumption.

Because Golding’s lab has been studying the effects of parental alcohol consumption on offspring — and has successfully correlated this consumption to a whole host of issues in children born to males who consumed excessive amounts of alcohol, including craniofacial abnormalities — his team was interested in the impacts of adding NAC or Se to a male mouse’s diet.

“We know alcohol causes oxidative stress and we were looking to push back on it by adding a supplement known to lower oxidative stress,” said Golding, a professor in the VMBS’ Department of Veterinary Physiology and Pharmacology. “When we realized that offspring born to males that had only been given NAC were displaying skull and facial differences, it was a surprise because this molecule is universally thought to be good.

“When we sat down to think it through, we realized that it makes sense — you take a multivitamin to ensure that you’re in balance, but if the thing that you’re taking to ensure you’re in balance is unbalanced (the dose of antioxidants is too high), then you’re not doing a good thing.”

It is well established that high doses of antioxidants can have negative impacts; research has proven that antioxidants can diminish the effects of exercise in endurance athletes, for example, and, in the case of professional athletes, can lead to negative outcomes in performance metrics.

“Sperm health is another performance metric; it’s just not one that we think about in everyday life,” Golding said. “If you’re taking a high dose antioxidant, you could be diminishing your reproductive fitness and part of the journey toward the bad outcome is going to be the effects on the offspring.”

What the face reveals about the brain

Among their unanticipated findings was that female offspring, in particular, exhibited significantly closer-set eyes and smaller skulls, which are also symptoms of fetal alcohol syndrome.

“There’s a very commonly accepted truism in pediatric medicine that the face mirrors the brain, because the brain and the face form at the same time,” Golding said. “When your face migrates (during gestation), it’s using cues from your brain to know where to go, and if the two things are not aligned, there’s either a delay or some kind of abnormality in brain development.

“So, if you see abnormalities in the midline of the face, you’re probably going to see midline abnormalities in the brain,” he said. “People with these abnormalities typically have problems with impulse control, neurological conditions like epilepsy, and other developmental issues.”

Whether the offspring in this project will exhibit central nervous system dysfunction will require further study.

The dose makes the difference

While the lab continues to research this “unexplored frontier,” Golding says in the case of antioxidants, too much of a good thing can, in fact, be too much, especially in the absence of a medical reason to take an antioxidant supplement.

Because many men regularly take high doses of these supplements — including products that contain antioxidant-rich ingredients — it’s important to pay attention to how much of these compounds are listed on the label. This includes NAC, which is one of the key ingredients in many multivitamins and is often found in high doses in these pills.

“The larger message here is that there’s a balance,” Golding said. “Think of yourself as a plant — if you stick your plant out in the sun too long, it’s going to get dehydrated. If you overwater your plant, it gets root rot. But if you have the right balance of sunshine and water, that’s when growth occurs. Health is in that domain.

“If your vitamins are providing 1,000% of the recommended daily amount, you should be cautious,” he said. “If you stick to the 100% range, then you should be OK.”

By Jennifer Gauntt, Texas A&M University College of Veterinary Medicine and Biomedical Sciences